日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trial

为评估恩格列净对2型糖尿病合并心血管疾病患者内皮功能的显著影响,开展了以下二次分析:恩格列净对心血管高危糖尿病患者内皮功能的安慰剂对照双盲随机效应研究:一项多中心安慰剂对照双盲随机试验

Tanaka, Atsushi; Shimabukuro, Michio; Machii, Noritaka; Teragawa, Hiroki; Okada, Yosuke; Shima, Kosuke R; Takamura, Toshinari; Taguchi, Isao; Hisauchi, Itaru; Toyoda, Shigeru; Matsuzawa, Yasushi; Tomiyama, Hirofumi; Yamaoka-Tojo, Minako; Ueda, Shinichiro; Higashi, Yukihito; Node, Koichi

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial

一项评估恩格列净对内皮功能影响的多中心、安慰剂对照、双盲随机试验的原理和设计:EMBLEM试验

Tanaka, Atsushi; Shimabukuro, Michio; Okada, Yosuke; Taguchi, Isao; Yamaoka-Tojo, Minako; Tomiyama, Hirofumi; Teragawa, Hiroki; Sugiyama, Seigo; Yoshida, Hisako; Sato, Yasunori; Kawaguchi, Atsushi; Ikehara, Yumi; Machii, Noritaka; Maruhashi, Tatsuya; Shima, Kosuke R; Takamura, Toshinari; Matsuzawa, Yasushi; Kimura, Kazuo; Sakuma, Masashi; Oyama, Jun-Ichi; Inoue, Teruo; Higashi, Yukihito; Ueda, Shinichiro; Node, Koichi

Autoimmune polyglandular syndrome type 3 with anorexia

自身免疫性多腺体综合征3型伴厌食症

Kahara, Toshio; Wakakuri, Hitomi; Takatsuji, Juri; Motoo, Iori; Shima, Kosuke R; Ishikura, Kazuhide; Usuda, Rika; Noda, Yatsugi